(19)
(11) EP 1 476 460 A2

(12)

(88) Date of publication A3:
29.07.2004

(43) Date of publication:
17.11.2004 Bulletin 2004/47

(21) Application number: 03709093.3

(22) Date of filing: 13.02.2003
(51) International Patent Classification (IPC)7C07K 1/00, C07K 16/00, C12P 21/06, G01N 33/53, C12N 15/00, C07H 21/02, C07H 21/04, A01N 37/18
(86) International application number:
PCT/US2003/004350
(87) International publication number:
WO 2003/068803 (21.08.2003 Gazette 2003/34)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 14.02.2002 US 356686 P
22.08.2002 GB 0219574

(71) Applicant: Aventis Pharmaceuticals Inc.
Bridgewater, New Jersey 08807-2854 (US)

(72) Inventors:
  • EISHINGDRELO, Haifeng
    Montville, NJ 07045 (US)
  • DRESSLER, Holly
    Franklin Park, NJ 08823 (US)
  • CAI, Jidong
    Whippany, NJ 07981 (US)
  • WRIGHT, Paul
    New Hope, PA 18938 (US)

(74) Representative: Bouvet, Philippe 
Aventis Pharma S.A.Direction des Brevets,Tri LEO/14420, avenue Raymond Aron
92165 Antony Cedex
92165 Antony Cedex (FR)

   


(54) A NUCLEIC ACID ENCODING A G-PROTEIN-COUPLED RECEPTOR; AND USES THEREOF